Literature DB >> 1891211

Molteno implantation for glaucoma in young patients.

R A Hill1, D K Heuer, G Baerveldt, D S Minckler, J F Martone.   

Abstract

Seventy patients younger than 21 years of age underwent Molteno implantation for nonneovascular glaucoma. Fifty-three (76%) patients had failed angle and/or conventional filtering surgery. Final intraocular pressure less than 22 mmHg (but over 5 mmHg) was achieved in 40 (62%) of the 65 patients with at least 6-month follow-up (range, 6 to 59 months; mean +/- standard deviation, 22.7 +/- 14.1 months); however, only 22 (34%) were controlled after the initial Molteno implantation procedure, and 54 (83%) patients underwent further glaucoma and/or nonglaucoma surgical procedures. The visual acuities remained within one line of their preoperative levels or improved in 25 (68%) of the 37 patients on whom Snellen acuities were available. The most frequent complications included: tube-cornea touch (20%, transient in 3%), corneal edema (17%), retinal detachment (16%), tube block (10%), cataract (9%), chronic hypotony or phthisis (9%), pupillary or cyclitic membrane (9%), hyphema (7%), flat anterior chamber (6%), and large postoperative choroidal effusion (6%). Despite the high rates of subsequent surgical interventions and complications, Molteno implantation has been a useful approach for achieving intraocular pressure reduction in young patients with glucoma.

Entities:  

Mesh:

Year:  1991        PMID: 1891211     DOI: 10.1016/s0161-6420(91)32179-1

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  20 in total

1.  Baerveldt glaucoma implant in paediatric patients.

Authors:  K A van Overdam; J T H N de Faber; H G Lemij; P W T de Waard
Journal:  Br J Ophthalmol       Date:  2006-03       Impact factor: 4.638

2.  Filtration procedures supplemented with mitomycin C in the management of childhood glaucoma.

Authors:  A Azuara-Blanco; R P Wilson; G L Spaeth; C M Schmidt; J J Augsburger
Journal:  Br J Ophthalmol       Date:  1999-02       Impact factor: 4.638

3.  Analysis of long-term outcomes for combined pars plana vitrectomy (PPV) and glaucoma tube shunt surgery in eyes with advanced glaucoma.

Authors:  A Gandhi; D M Miller; J M Zink; A K Khatana; C D Riemann; M R Petersen; R E Foster; R A Sisk
Journal:  Eye (Lond)       Date:  2013-12-13       Impact factor: 3.775

Review 4.  Endophthalmitis associated with the Ahmed glaucoma valve implant.

Authors:  A A Al-Torbak; S Al-Shahwan; I Al-Jadaan; A Al-Hommadi; D P Edward
Journal:  Br J Ophthalmol       Date:  2005-04       Impact factor: 4.638

Review 5.  Childhood glaucoma surgery in the 21st century.

Authors:  M Papadopoulos; B Edmunds; C Fenerty; P T Khaw
Journal:  Eye (Lond)       Date:  2014-06-13       Impact factor: 3.775

6.  Long-term outcomes of glaucoma drainage devices for glaucoma post-vitreoretinal surgery with silicone oil insertion: a prospective evaluation.

Authors:  Shikha Gupta; Abadh K Chaurasia; Rohan Chawla; Kulwant Singh Kapoor; Karthikeyan Mahalingam; Deepa R Swamy; Viney Gupta
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-08-18       Impact factor: 3.117

7.  Evaluation of Ahmed glaucoma valve implantation through a needle-generated scleral tunnel in Mexican children with glaucoma.

Authors:  Oscar Albis-Donado; Félix Gil-Carrasco; Rafael Romero-Quijada; Ravi Thomas
Journal:  Indian J Ophthalmol       Date:  2010 Sep-Oct       Impact factor: 1.848

8.  The Armenian Eye Care Project: surgical outcomes of complicated paediatric glaucoma.

Authors:  R Hill; R Ohanesian; L Voskanyan; A Malayan
Journal:  Br J Ophthalmol       Date:  2003-06       Impact factor: 4.638

9.  Ahmed glaucoma valve in children: A review.

Authors:  Nariman Nassiri; Kouros Nouri-Mahdavi; Anne L Coleman
Journal:  Saudi J Ophthalmol       Date:  2011-07-30

10.  Prognostic factors and postoperative course following single-plate Molteno implantation.

Authors:  W C Stewart; A B Connor; R A Pitts
Journal:  Doc Ophthalmol       Date:  1994       Impact factor: 2.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.